LMRI

Lumexa Imaging Holdings, Inc.

Nasdaq · Services-Medical Laboratories · Inc. DE · CIK 0002071288
$9.64 +1.26% $926.2M
High Impact Filing (7/10)7 New Institutional Positions3 Institutional Exits
Vol
Market Cap$926.2M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (93%)
Inst. Holders46 funds
Inst. Value$199.6M
Inst. Activity7 buys / 3 sells
Insider Activity2B / 0S
Insider Net $$476.9K
SEC Reports2
Exchange Nasdaq·Sector Services-Medical Laboratories·Inc. DE·CIK 0002071288·Prev Close $9.52

Recent Activity

Jun 10, 2026 Insider
EISENBERG GLENN A was granted 19,358 shares
Director
Jun 10, 2026 Insider
Joseph Molly was granted 19,358 shares
Director
Jun 10, 2026 Insider
Cooper Henry Lee was granted 19,358 shares
Director
May 12, 2026 SEC
Lumexa Imaging reported Q1 2026 GAAP EPS of $0.02, a massive miss vs the $0.12 consensus, and revenue of $252.5M slightl
PRESS-RELEASE — Impact 7/10
May 12, 2026 SEC
Lumexa Imaging reported Q1 2026 revenue of $252.5M (+3.1% YoY), slightly above consensus of $251.2M, and GAAP EPS of $0.
8-K — Impact 4/10
Inst.
MASSACHUSETTS FINANCIAL SERVICES CO — DOUBLED
2,334,580 shares ($20.1M)
Inst.
BlackRock, Inc. — DOUBLED
1,525,683 shares ($13.1M)
May 12, 2026 earnings
Lumexa Imaging Announces First Quarter 2026 Results
<p align="justify">RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI),

Price Targets

$17.29 +79.3% upside Strong Buy
Current $9.64 Low $9.00 Median $18.00 High $23.00 7 analysts
$9.00 $23.00

Analyst Ratings

Strong Buy93% buy · 14 analysts
6Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 20, 2026 Barclays MAINTAIN Overweight → Overweight
Apr 14, 2026 Barclays MAINTAIN Overweight → Overweight
Feb 9, 2026 Raymond James UPGRADE Outperform → Strong Buy
Jan 5, 2026 Raymond James INITIATE Outperform
Jan 5, 2026 Barclays INITIATE Overweight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $0.14 $0.10 — $0.16 5
Next Q $0.19 $0.16 — $0.21 5
Current FY $0.70 $0.49 — $0.77 291% YoY 5
Next FY $0.89 $0.79 — $1.06 27% YoY 5

Top Institutional Holders

FundValueMove
ALLIANCEBERNSTEIN L.P.$55.1MNEW
MASSACHUSETTS FINANCIAL SERVICES CO$20.1MDOUBLED
JANUS HENDERSON GROUP PLC$18.1MNEW
BlackRock, Inc.$13.1MDOUBLED
Invesco Ltd.$12.4MNEW

Recent Insider Trades

DateInsiderTypeValue
Jun 10, 2026EISENBERG GLENNA$0.00
Jun 10, 2026Joseph MollyA$0.00
Jun 10, 2026Cooper HenryA$0.00
Jun 10, 2026Mittl RobertA$0.00
Jun 10, 2026BRODNAX BRETTA$0.00
46 institutional holders with $199.6M total value (19,797,361 shares) as of 2026-Q1. Top holders: ALLIANCEBERNSTEIN, MASSACHUSETTS, JANUS. Net buying activity: 7 institutions added/increased vs 3 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1ALLIANCEBERNSTEIN L.P.2,980,462$55.1M27.6%NEW
2MASSACHUSETTS FINANCIAL SERVICES CO /MA/2,334,580$20.1M10.1%DOUBLED +133.5%
3JANUS HENDERSON GROUP PLC2,100,356$18.1M9.0%NEW
4BlackRock, Inc.1,525,683$13.1M6.6%DOUBLED +1425.7%
5Invesco Ltd.1,440,542$12.4M6.2%NEW
6HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND1,300,000$11.2M5.6%NEW
7VANGUARD CAPITAL MANAGEMENT LLC1,058,486$9.1M4.6%
8FMR LLC794,589$6.8M3.4%NEW
9GOLDMAN SACHS GROUP INC765,509$6.6M3.3%
10CITADEL ADVISORS LLC656,585$5.6M2.8%
11RTW INVESTMENTS, LP650,000$5.6M2.8%NEW
12FEDERATED HERMES, INC.570,000$4.9M2.5%ADD +26.7%
13Woodline Partners LP532,098$4.6M2.3%NEW
14ADAGE CAPITAL PARTNERS GP, L.L.C.418,528$3.6M1.8%TRIM -60.0%
15STATE STREET CORP376,792$3.2M1.6%
16ROYCE & ASSOCIATES LP330,000$2.8M1.4%
17FRANKLIN RESOURCES INC322,901$2.8M1.4%
18KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC305,577$2.6M1.3%DOUBLED +191.0%
19CHARLES SCHWAB INVESTMENT MANAGEMENT INC209,451$1.8M0.9%
20VANGUARD FIDUCIARY TRUST CO161,351$1.4M0.7%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
MASSACHUSETTS FINANCIAL SERVICES CO /MA/DOUBLED1,000,0132,334,580+133.5%$20.1M2026-Q1
BlackRock, Inc.DOUBLED100,0001,525,683+1425.7%$13.1M2026-Q1
FEDERATED HERMES, INC.ADD450,000570,000+26.7%$4.9M2026-Q1
ADAGE CAPITAL PARTNERS GP, L.L.C.TRIM1,046,788418,528-60.0%$3.6M2026-Q1
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLCDOUBLED105,000305,577+191.0%$2.6M2026-Q1
BANK OF AMERICA CORP /DE/DOUBLED6111,313+1855116.7%$957.3K2026-Q1
MORGAN STANLEYDOUBLED17,533104,430+495.6%$898.1K2026-Q1
SEI INVESTMENTS CODOUBLED20,06388,190+339.6%$758.4K2026-Q1
Legal & General Group PlcNEAR_EXIT15,0002,209-85.3%$19.0K2026-Q1
BALYASNY ASSET MANAGEMENT L.P.EXIT1,134,5720-100.0%$0.002026-Q1
ALLIANCEBERNSTEIN L.P.NEW3,238,479$59.9M2025-Q4
JANUS HENDERSON GROUP PLCNEW1,992,453$36.9M2025-Q4
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUNDNEW1,500,000$27.8M2025-Q4
Invesco Ltd.NEW1,435,807$26.6M2025-Q4
BALYASNY ASSET MANAGEMENT L.P.NEW1,134,572$21.0M2025-Q4
ADAGE CAPITAL PARTNERS GP, L.L.C.NEW1,046,788$19.4M2025-Q4
MASSACHUSETTS FINANCIAL SERVICES CO /MA/NEW1,000,013$18.5M2025-Q4
FMR LLCNEW681,700$12.6M2025-Q4
Woodline Partners LPNEW681,163$12.6M2025-Q4
RTW INVESTMENTS, LPNEW650,000$12.0M2025-Q4
8 unique insiders with 10 transactions. Net insider value: $476.9K ($476.9K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 10, 2026EISENBERG GLENN ADirectorAWARD19,358
Jun 10, 2026Joseph MollyDirectorAWARD19,358
Jun 10, 2026Cooper Henry LeeDirectorAWARD19,358
Jun 10, 2026Mittl Robert Louis Jr.DirectorAWARD19,358
Jun 10, 2026BRODNAX BRETTDirectorAWARD19,358
Jun 10, 2026Karlin Bridget EDirectorAWARD19,358
Jun 10, 2026Lungren MatthewDirectorAWARD19,358
May 19, 2026BRODNAX BRETTDirectorBUY35,000$7.25$253.8K
May 14, 2026Cooper Henry LeeDirectorBUY30,000$7.44$223.1K
Feb 25, 2026Walker James Edward Jr.Principal Accounting OfficerAWARD12,414

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (93% buy). Based on 14 analysts: 6 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$17.29 mean target +79.3% upside Strong Buy (1.25)
$9.00 Low $23.00 High
MetricValue
Current Price$9.64
Target Low$9.00
Target Mean$17.29
Target Median$18.00
Target High$23.00
# Analysts7
RecommendationStrong Buy (1.25)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.14 $0.10 $0.16 1↑ 4↓ $0.3B 5
Next Q
2026-09-30
$0.19 $0.16 $0.21 2↑ 2↓ $0.3B 5
Current FY
2026-12-31
$0.70 $0.49 $0.77 290.9% 2↑ 2↓ $1.1B 4.3% 5
Next FY
2027-12-31
$0.89 $0.79 $1.06 27.4% 2↑ 2↓ $1.1B 5.5% 5

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.142
7d ago$0.163-0.021
30d ago$0.000+0.142
60d ago$0.161-0.019
90d ago$0.172-0.030
7 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 7 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 20, 2026 Barclays MAINTAIN Overweight Overweight
Apr 14, 2026 Barclays MAINTAIN Overweight Overweight
Feb 9, 2026 Raymond James UPGRADE Outperform Strong Buy
Jan 5, 2026 Raymond James INITIATE Outperform
Jan 5, 2026 Barclays INITIATE Overweight
Jan 5, 2026 Wells Fargo INITIATE Overweight
Jan 5, 2026 William Blair INITIATE Outperform
Jan 5, 2026 Deutsche Bank INITIATE Buy
Jan 5, 2026 Leerink Partners INITIATE Outperform
Jan 5, 2026 Jefferies INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20266710093%
May 1, 20266710093%
Apr 1, 20266710093%
Mar 1, 20264710092%
Feb 1, 20263810092%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 12, 2026
earnings
Lumexa Imaging Announces First Quarter 2026 Results
<p align="justify">RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpatien
May 12, 2026
earnings_calendar
LMRI Q1 2026 Earnings Scheduled — 2026-05-12
Apr 28, 2026
earnings
Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date
<p align="justify">RALEIGH, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=4pMVR2FjpPusR61cyoQsY1uu-54
Apr 20, 2026
other
Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer
Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa Imaging’s platform <pre>Proven healthcare growth le
Apr 1, 2026
short_volume
Short Volume: LMRI — 78.8% short (0.6M / 0.8M)
Short: 643,919 | Exempt: 1,000 | TRF Vol: 816,808 | Short Ratio: 78.8% | Off-exchange volume (dark pool + OTC)
Mar 27, 2026
short_volume
Short Volume: LMRI — 71.0% short (0.6M / 0.9M)
Short: 617,716 | Exempt: 57,539 | TRF Vol: 869,833 | Short Ratio: 71.0% | Off-exchange volume (dark pool + OTC)
Mar 26, 2026
earnings
Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance
<p align="justify">RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest providers of outpati
Mar 26, 2026
earnings_calendar
LMRI Q4 2025 Earnings Scheduled — 2026-03-26
Mar 26, 2026
short_volume
Short Volume: LMRI — 65.3% short (0.8M / 1.2M)
Short: 805,876 | Exempt: 34,706 | TRF Vol: 1,233,591 | Short Ratio: 65.3% | Off-exchange volume (dark pool + OTC)
Mar 25, 2026
short_interest
FTD: LMRI — 95,971 shares ($1.0M) failed to deliver
Settlement: 20260325, Price: $10.84, FTD Value: $1,040,325.64, LUMEXA IMAGING HLDGS INC COM
Mar 23, 2026
short_interest
FTD: LMRI — 482,612 shares ($5.7M) failed to deliver
Settlement: 20260323, Price: $11.84, FTD Value: $5,714,126.08, LUMEXA IMAGING HLDGS INC COM